Development of a preclinical nephrotoxicity screening plan
Ended Awarded Last action
- Contract number
- 75N93022F00002
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $49,839
Award facts
- Contract value 100% obligated
- $49,839.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $49,839 |
Quick answers
Who was awarded contract 75N93022F00002?
75N93022F00002 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 3, 2022.
How much is contract 75N93022F00002 worth?
The government has obligated $49,839 on 75N93022F00002.
Is contract 75N93022F00002 an order under another contract?
Yes. 75N93022F00002 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93022F00002 competed?
The extent of competition for 75N93022F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award